ADXN

Addex Therapeutics
ADXN

Overview Fund Trends Analyst Outlook Journalist POV

5 hedge funds and large institutions have $3.46K invested in Addex Therapeutics in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$699

Top Sellers

1
-$86.2K
2
-$10.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
GI
1
GAMMA Investing
California
$1.14K
Morgan Stanley
2
Morgan Stanley
New York
$941
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$699
RhumbLine Advisers
4
RhumbLine Advisers
Massachusetts
$637
SS
5
SBI Securities
Japan
$47
Citadel Advisors
6
Citadel Advisors
Florida
–